Latest News

Pharmaceutical Five things for pharma marketers to know: Tuesday, July 7

Five things for pharma marketers to know: Tuesday, July 7

Groups urge disclosure of payments to nurse practitioners and physician assistants; Horizon seeks $3-billion acquisition of Depomed; Sanofi closes $245-million agreement to buy priority-review voucher

Pharmaceutical Curious if you're a finalist in the MM&M Awards? Find out now

Curious if you're a finalist in the MM&M Awards? Find out now

The finalists in each of the 32 categories for this year's MM&M Awards are revealed here.

Pharmaceutical Vertex's Orkambi nabs FDA approval but may face payer backlash

Vertex's Orkambi nabs FDA approval but may face payer backlash

The Boston-based biotech saw its novel cystic-fibrosis drug, Orkambi, receive approval, but it could face an uphill climb in convincing payers to pay for it.

MedTech

Fit4D expands diabetes program with Healthfirst

The health insurer will offer Fit4D's diabetes coaching program to its members after testing the program during a pilot last year.

Legal/Regulatory Steady Leadership, Focus on Infrastructure Expected from the FDA's "Acting" Head

Steady Leadership, Focus on Infrastructure Expected from the FDA's "Acting" Head

Dr. Stephen Ostroff took over as the FDA's acting commissioner when Dr. Margaret Hamburg stepped down in March.

Pharmaceutical Five things for pharma marketers to know: Monday, July 6

Five things for pharma marketers to know: Monday, July 6

Vertex's cystic-fibrosis drug scores approval; Bloomberg Business analysis finds competitive product categories attract the most marketing dollars; Allergan makes a deal with developmental medical-device company

Top 100 Agencies

Index of Agencies and Advertisers

Please open the PDF (named Index) below for a complete listing from our July 2015 issue

Top 100 Agencies MM&M's Agency Solar System

MM&M's Agency Solar System

North American healthcare agencies and the holding companies that own them

Pharmaceutical Five things for pharma marketers to know: Thursday, July 2

Five things for pharma marketers to know: Thursday, July 2

Biogen pursues orphan eye-disease treatments; Novo Nordisk will stop selling Tresiba in Germany over price controversy; the switch to Prevnar 13 is expected to lower costs

Top 100 Agencies Top 100 Agencies 2015: Wunderman Health

Top 100 Agencies 2015: Wunderman Health

Digital accounts for more than happiness